文献速递免疫规划传染病防控与疫情报告卫生政策与健康促进

利用病历与索赔数据评估2018-2019年度流感疫苗对就医性流感样病例的有效性

Evaluation of the 2018-2019 vaccine effectiveness against medically attended influenza-like illness using medical records and claims data.
PubMed 文献 · Vaccine · 2022-08-27

这项回顾性队列研究利用电子病历与索赔数据,纳入5,066,980人,评估2018-2019年度标准鸡胚流感疫苗对就医性流感样病例(MA-ILI)的有效性。儿童中疫苗保护效果为中等,成人中较低,所有估计值均低于美国CDC报告的同季疫苗有效性;按初级保健就诊次数分层后,就诊≥6次者的调整疫苗有效性与CDC估计相近。

要点

  • 儿童中疫苗对MA-ILI的保护效果为中等,成人中较低。
  • 所有调整疫苗有效性估计均低于CDC报告的2018-2019年度疫苗有效性。
  • 按初级保健就诊次数分层后,就诊≥6次者的调整疫苗有效性与CDC估计相近。

核心结论

  • 利用行政医疗数据观察到2018-2019年度调整疫苗有效性为中等和较低水平,可能源于与就医行为相关的检测偏倚和错分偏倚,导致该年度流感疫苗有效性被低估。

研究设计与样本

  • 回顾性队列研究,于2018-2019年度流感季节开展,纳入2015至2019年间每年电子病历中至少有1条相关记录者,共5,066,980人,其中1,307,702人(25.8%)被判定为已接种疫苗。

主要发现

  • 总体中位年龄为54岁(IQR 32-66),女性占58.1%。
  • 接种疫苗后14天起被视为已获保护,结局为按临床诊断代码定义的就医性流感样病例(MA-ILI)。
  • 儿童中疫苗对MA-ILI的保护效果为中等,成人中较低。
  • 所有调整疫苗有效性估计值均低于美国CDC报告的2018-2019年度疫苗有效性。
  • 按初级保健就诊次数分层后,调整疫苗有效性估计值和疫苗接种覆盖率随就诊次数增加而升高,就诊≥6次者的估计值与CDC及美国国家疫苗接种覆盖率相近,在频繁就医者中呈现显著正向疫苗保护。

临床怎么用

  • 作者指出,行政医疗数据得到的调整疫苗有效性可能因检测偏倚和错分偏倚而被低估,该偏倚与就医行为相关。

局限性

  • 错分偏倚和残余混杂导致2018-2019年度调整疫苗有效性被低估。
  • 作者指出,结果对潜在的失访偏倚稳健。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Healthcare administrative databases are a rich source of information that could be leveraged to estimate real-world influenza vaccine effectiveness (VE). We aimed to evaluate the VE of standard egg-based influenza vaccines and determine if administrative healthcare data provide accurate VE estimates compared to the US CDC data. METHODS: This retrospective cohort study was conducted during the 2018-2019 influenza season. Individuals who had at least one relevant record per year between 2015 and 2019 in their electronic medical record were included. Individuals were considered protected 14 days after receiving an influenza vaccine. The outcome was the occurrence of medically attended influenza-like illness (MA-ILI) defined by clinical diagnostic codes. Adjusted odds ratios (aORs) were derived from multivariate logistic regression and adjusted VE (aVEs) were calculated using 100 × (1-aORs). RESULTS: A total of 5,066,980 individuals were included in the analysis with 1,307,702 (25.8%) considered vaccinated. Overall, the median age was 54 (IQR, 32-66) and 58.1% were female. Vaccine protection against MA-ILI was moderate in children and low in adults. All estimates were lower than VEs reported by the CDC for the 2018-2019 influenza season. Our results were robust to potential loss to follow up, but misclassification bias and residual confounding led to underestimation of the 2018-2019 aVE. When stratified by the number of primary care visits, aVE estimates and vaccination coverage increased with the number of primary care visits, reaching estimates similar to those obtained by the US CDC and US national vaccination coverage among those with ≥ 6 primary care visits, resulting in significant positive vaccine protection in frequent healthcare users. CONCLUSIONS: Moderate and low aVEs were observed during the 2018-2019 season using administrative healthcare data, which was likely due to detection and misclassification biases, correlated with healthcare seeking behaviour, leading to an underestimation of the 2018-2019 influenza VE.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Doyon-Plourde P, Fortin É, Quach C, et al. Evaluation of the 2018-2019 vaccine effectiveness against medically attended influenza-like illness using medical records and claims data. Vaccine. 2022. PMID: 36041941. doi:10.1016/j.vaccine.2022.08.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。